+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Burn Ointment Market By Depth of Burn, By Product, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

  • PDF Icon

    Report

  • 71 Pages
  • January 2021
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5241396
The North America Burn Ointment Market is expected to witness market growth of 5% CAGR during the forecast period (2020-2026).

Burns is considered as one of the most common injuries in which skin is damaged due to heat exposure. In burn injuries, one or more layers of skin and flesh is damaged by external heat or chemical sources. Burns are categorized from minor to major, starting from first degree to fourth degree, each degree is nothing but a higher level of damage. For successful treatment of the burns, proper understanding and identifying burns degree is important.

In first-degree burns, or superficial burns, there is pain redness, and minor swelling on the skin. Second degree burns affect slight thickness of skin and also damage the underlying layer of burned areas. In third-Degree burns, the dermis and surrounding nerves get damaged. Fourth-degree burns result in charring and irreparable damage. First-Degree and Second-Degree burns can be treated with skincare products like antiseptic creams, antibiotic ointment and using dry gauze bandage over the skin that protects the burned area. Treatment and cure of third-degree burns require skin grafting or synthetic skin for complete recovery of damaged skin.

The hydrocolloid dressing is a burn care accessory that have inner gel-forming agents and outer flexible water-resistant layer that is used for moderate burn wounds. Burn care products & accessories also include burn dressings, moist burn pads, water gel spray, hydrogel, Non-adherent pads, and hydrocolloid, collagen, and alginate dressings. For higher degree burns treatment wound dressing, medication, therapy, and surgery are done to control pain, prevent infection, and removing dead cells.

Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.

Scope of the Study

Market Segments covered in the Report:

By Depth of Burn
  • Minor Burns
  • Partial Thickness Burns
  • Full Thickness Burns

By Product
  • Topical Antibiotics
  • Silver
  • Iodine
  • Other Products

By End Use
  • Clinics
  • Hospitals
  • Other End Use

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled
  • Johnson and Johnson
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Perrigo Company PLC
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Dr. Morepen Limited
  • Mankind Pharma Ltd.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Burn Ointment Market, by Depth of Burn
1.4.2 North America Burn Ointment Market, by Product
1.4.3 North America Burn Ointment Market, by End Use
1.4.4 North America Burn Ointment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Burn Ointment Market by Depth of Burn
3.1 North America Minor Burns Market by Country
3.2 North America Partial Thickness Burns Market by Country
3.3 North America Full Thickness Burns Market by Country
Chapter 4. North America Burn Ointment Market by Product
4.1 North America Topical Antibiotics Market by Country
4.2 North America Silver Market by Country
4.3 North America Iodine Market by Country
4.4 North America Other Products Market by Country
Chapter 5. North America Burn Ointment Market by End Use
5.1 North America Clinics Burn Ointment Market by Country
5.2 North America Hospitals Market by Country
5.3 North America Other End Use Market by Country
Chapter 6. North America Burn Ointment Market by Country
6.1 US Burn Ointment Market
6.1.1 US Burn Ointment Market by Depth of Burn
6.1.2 US Burn Ointment Market by Product
6.1.3 US Burn Ointment Market by End Use
6.2 Canada Burn Ointment Market
6.2.1 Canada Burn Ointment Market by Depth of Burn
6.2.2 Canada Burn Ointment Market by Product
6.2.3 Canada Burn Ointment Market by End Use
6.3 Mexico Burn Ointment Market
6.3.1 Mexico Burn Ointment Market by Depth of Burn
6.3.2 Mexico Burn Ointment Market by Product
6.3.3 Mexico Burn Ointment Market by End Use
6.4 Rest of North America Burn Ointment Market
6.4.1 Rest of North America Burn Ointment Market by Depth of Burn
6.4.2 Rest of North America Burn Ointment Market by Product
6.4.3 Rest of North America Burn Ointment Market by End Use
Chapter 7. Company Profiles
7.1 Johnson and Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.2 ConvaTec Group PLC
7.2.1 Company Overview
7.2.1 Financial Analysis
7.2.2 Regional Analysis
7.2.3 Research & Development Expense
7.3 Smith & Nephew PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Approvals:
7.6 Perrigo Company PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Cipla Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Dr. Morepen Limited
7.9.1 Company Overview
7.10. Mankind Pharma Ltd.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:

Companies Mentioned

  • Johnson and Johnson
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Perrigo Company PLC
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Dr. Morepen Limited
  • Mankind Pharma Ltd.

Methodology

Loading
LOADING...